Your browser doesn't support javascript.
loading
Next generation of immune checkpoint molecules in maternal-fetal immunity.
Zhao, Si-Jia; Muyayalo, Kahindo P; Luo, Jing; Huang, Donghui; Mor, Gil; Liao, Ai-Hua.
Afiliación
  • Zhao SJ; Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Muyayalo KP; Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Luo J; Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Huang D; Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Mor G; Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liao AH; C.S. Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan, USA.
Immunol Rev ; 308(1): 40-54, 2022 07.
Article en En | MEDLINE | ID: mdl-35234305
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_mortalidade_materna Asunto principal: Receptor de Muerte Celular Programada 1 / Proteínas de Punto de Control Inmunitario Límite: Female / Humans / Pregnancy Idioma: En Revista: Immunol Rev Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_mortalidade_materna Asunto principal: Receptor de Muerte Celular Programada 1 / Proteínas de Punto de Control Inmunitario Límite: Female / Humans / Pregnancy Idioma: En Revista: Immunol Rev Año: 2022 Tipo del documento: Article País de afiliación: China